KMS Group

Mumbai, India Founded: 1999 • Age: 27 yrs Listed
Surgical adhesive tapes and wound dressings are developed by KMS.

About KMS Group

KMS Group is a publicly listed company based in Mumbai (India) founded in 1999 by Gaurang Prataprai Kanakia. Surgical adhesive tapes and wound dressings are developed by KMS. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its chief executive, as recorded, is Gaurang Prataprai Kanakia. Its Indian entity Kms Medisurgi Limited reported revenue of β‚Ή12.22 Cr. KMS Group offers products and services including Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing. Its focus areas include Medical Devices and Wound Care Products.

Company details

KMS Group is focused on the production of surgical and advanced wound care products. The company is headquartered in Mumbai, India, with a manufacturing unit in Palghar. Operations are extended to both domestic and international markets through a widespread supply chain. Products are developed through market research to meet customer needs in the healthcare sector. Cost-efficient solutions are provided to ensure ease of usage and quality assurance. Long-term partnerships are cultivated to strengthen presence in the industry.

  • Headquarters Mumbai, India
  • Founders Gaurang Prataprai Kanakia
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website kmsgroup.in
  • Legal Name Kms Medisurgi Ltd.
Operational Areas
Key Metrics
  • Market Cap
    ₹43.82 Cr

    KMSMEDI · BSE

  • Share Price
    ₹132.80

    0.00% today

  • Revenue
    ₹12.21 Cr

    FY 2025-26 · -12.4% YoY

  • EBITDA
    ₹0.94 Cr

    Margin 7.7%

  • Net Profit
    ₹0.25 Cr

    FY 2025-26 · -41.9% YoY

  • P/E (TTM)
    99.6x

    P/B 5.4x

  • ROE
    3.0%

    ROCE 5.2%

  • Debt / Equity
    0.10

    Interest cover 29.8x

Products & Services of KMS Group

KMS Group offers a comprehensive portfolio of products and services, including Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing.

Advanced Wound Care
Healthcare

Advanced wound care products are developed for healing.

Surgical Tapes
Healthcare

Surgical tapes are provided for medical securing needs.

5 Layer Silicone Foam Dressing
Healthcare

Silicone foam dressings are offered for wound protection.

Board of directors of Kms Medisurgi Limited (KMS Group)

Kms Medisurgi Limited is the primary company behind KMS Group. The boards of the 3 registered companies of KMS Group currently have 10 directors; the longest-serving is Amrita Gaurang Kanakia, appointed in 2001. 12 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amrita Gaurang Kanakia
DIN 00346183
Director10 Dec 200124 yrs 10 moKms Stock Broking Company Private Limited
Anand Prataprai Kanakia
DIN 00285357
Director10 Dec 200124 yrs 10 moKms Stock Broking Company Private Limited
Hardik Rajnikant Bhatt
DIN 07566870
Director14 Jul 201610 yrs 3 moKms Medisurgi Limited
Kamlesh Chunilal Rajani
DIN 07588417
Director11 Aug 201610 yrs 2 moKms Medisurgi Limited
Rekha Devang Kanakia
DIN 00346198
Director30 Jan 20179 yrs 8 moKms Manufacturing Limited
Gaurang Prataprai Kanakia
DIN 00346180
Director30 Jan 20179 yrs 8 moKms Manufacturing Limited, Kms Medisurgi Limited
Siddharth Gaurang Kanakia
DIN 07595098
Director30 Jan 20179 yrs 8 moKms Manufacturing Limited, Kms Medisurgi Limited
Pratik Pravin Tarpara
DIN 08689556
Director12 Feb 20206 yrs 8 moKms Medisurgi Limited
Rohan Devang Kanakia
DIN 09220915
Director29 Jun 20215 yrs 4 moKms Medisurgi Limited
Monali Gaurang Kanakia
DIN 10135949
Director03 May 20233 yrs 5 moKms Medisurgi Limited

People of KMS Group

1 people are tracked at KMS Group (1 in leadership).

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for KMS Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of KMS Group

KMS Group is a publicly listed company on the BSE with ticker symbol KMSMEDI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date24 Apr 2017
  • Listed onBSE: 540468
  • Listed entityKMS Medisurgi Ltd.
  • Exchange sectorHealth technology
  • ISININE870V01014
  • Share price₹126.50 · 2026-05-11
  • Market capitalisation₹41.7 Cr
  • Price to earnings70.5
  • EPS (diluted, trailing year)₹1.80
  • Dividend yield0.04%
  • Volume (last session)1,000
  • Analyst consensusNo rating

Financials of KMS Group

Exchange-reported figures of Kms Medisurgi Limited, the listed company behind KMS Group (BSE: KMSMEDI).

Financial Highlights

FY 2025-26 Β· Standalone
Revenue
₹12.21 Cr
-12.4% YoY
EBITDA
₹0.94 Cr
0.0% YoY
Profit After Tax
₹0.25 Cr
-41.9% YoY
Net Worth
₹8.31 Cr
+2.7% YoY
Total Assets
₹9.09 Cr
+1.0% YoY
Total Debt
₹0.77 Cr
-15.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue12.2113.9413.8811.0310.327.5110.34
Revenue growth-12.4%+0.4%+25.8%+6.9%+37.4%-27.4%-
EBITDA0.940.940.780.980.530.510.65
EBITDA margin+7.7%+6.7%+5.6%+8.9%+5.1%+6.8%+6.3%
Profit before tax0.340.600.600.680.290.250.17
Net profit0.250.430.490.590.220.140.10
Net profit margin+2.1%+3.1%+3.5%+5.4%+2.1%+1.9%+1.0%
EPS (β‚Ή)0.741.331.381.740.650.370.34
Balance sheet
Total assets9.099.008.208.227.667.487.45
Net worth8.318.097.667.236.676.456.35
Total debt0.770.910.540.990.991.031.11
Cash & bank1.100.470.420.190.400.610.29
Net working capital5.865.976.286.226.075.825.64
Cash flow
Cash from operations1.510.741.210.46(0.07)0.53(0.84)
Cash from investing(0.61)(0.96)(0.51)(0.66)(0.12)(0.10)0.01
Cash from financing(0.26)0.27(0.47)(0.01)(0.02)(0.11)(0.06)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 29 Oct 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue12.2113.9413.8811.0310.327.5110.34
Revenue growth-12.4%+0.4%+25.8%+6.9%+37.4%-27.4%-
Other income0.010.030.090.020.050.100.00
Total expenses11.2713.0013.1010.059.797.009.69
Employee cost1.161.051.170.960.790.680.76
EBITDA0.940.940.780.980.530.510.65
EBITDA margin+7.7%+6.7%+5.6%+8.9%+5.1%+6.8%+6.3%
Depreciation0.470.270.250.320.290.330.41
Interest0.140.100.020.000.000.030.07
Profit before tax0.340.600.600.680.290.250.17
Tax0.090.170.150.090.070.110.07
Net profit0.250.430.490.590.220.140.10
Net profit margin+2.1%+3.1%+3.5%+5.4%+2.1%+1.9%+1.0%
EPS (β‚Ή)0.741.331.381.740.650.370.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital3.303.303.303.303.303.303.30
Reserves & surplus5.014.794.363.933.373.153.05
Shareholders' funds (net worth)8.318.097.667.236.676.456.35
Secured loans0.000.000.000.000.000.050.13
Unsecured loans0.770.910.540.990.990.980.98
Total debt0.770.910.540.990.991.031.11
Total liabilities9.099.008.208.227.667.487.45
Assets
Gross block7.265.545.245.935.275.154.98
Net block2.931.681.651.821.481.651.81
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.00
Inventories2.542.522.090.920.970.671.35
Sundry debtors3.224.245.786.546.546.285.50
Cash & bank balances1.100.470.420.190.400.610.29
Loans & advances0.460.080.640.080.330.120.15
Total current assets7.327.318.937.738.247.687.29
Total current liabilities1.461.342.651.512.171.861.65
Net working capital5.865.976.286.226.075.825.64
Total assets9.099.008.208.227.667.487.45
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.470.420.190.400.610.291.18
Net cash from operating activities1.510.741.210.46(0.07)0.53(0.84)
Net cash from investing activities(0.61)(0.96)(0.51)(0.66)(0.12)(0.10)0.01
Net cash from financing activities(0.26)0.27(0.47)(0.01)(0.02)(0.11)(0.06)
Net change in cash0.640.050.23(0.21)(0.21)0.32(0.88)
Closing cash1.100.470.420.190.400.610.29
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-12.4%+0.4%+25.8%+6.9%+37.4%-27.4%-
EBITDA growth0.0%+20.5%-20.4%+84.9%+3.9%-21.5%-
PBT growth-43.3%0.0%-11.8%+134.5%+16.0%+47.1%-15.0%
Net income growth-41.9%-12.2%-17.0%+168.2%+57.1%+40.0%-
Revenue CAGR (3Y)+3.5%+10.5%+22.7%+2.2%+1.5%+0.9%+9.4%
EBITDA CAGR (3Y)-1.4%+21.1%+15.2%+14.7%+20.9%+2.8%-11.3%
Profitability & leverage
Net income margin+2.1%+3.1%+3.2%+5.4%+2.1%+1.9%+1.0%
Return on capital employed+5.2%+8.3%+7.6%+8.3%+3.8%+3.5%+3.4%
Return on net worth+3.1%+5.6%+6.0%+8.2%+3.4%+1.9%+1.8%
Debt / equity0.100.090.100.140.150.170.18
Long-term debt / equity0.100.090.100.140.150.170.18
Interest cover29.7914.933.770.000.0016.6729.17
Efficiency & per share
Fixed asset turnover1.912.592.491.971.981.482.08
Inventory turnover4.836.059.2211.6712.597.446.54
Debtors turnover3.272.782.251.691.611.281.96
EPS (β‚Ή)0.741.331.381.740.650.370.34
Dividend per share (β‚Ή)0.050.050.050.050.050.050.05
Book value per share (β‚Ή)25.2024.5023.2221.8920.2119.5619.23

Web traffic of KMS Group

The website of KMS Group (kmsgroup.in) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 31.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kms Group

Premium access

Complete news archive for KMS Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KMS Group

KMS Group was founded in 1999.

KMS Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Gaurang Prataprai Kanakia is the CEO of KMS Group, as recorded in our data. They have also founded this company.

The primary company behind KMS Group, Kms Medisurgi Limited, reported revenue of β‚Ή12.22 Cr for FY 2026, down 12% year on year.

KMS Group is focused on the production of surgical and advanced wound care products. The company is headquartered in Mumbai, India, with a manufacturing unit in Palghar. Operations are extended to both domestic and international markets through a widespread supply chain. Products are developed through market research to meet customer needs in the healthcare sector. Cost-efficient solutions are provided to ensure ease of usage and quality assurance. Long-term partnerships are cultivated to strengthen presence in the industry.

KMS Group offers Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing.

Yes, KMS Group is publicly traded on BSE under the ticker symbol KMSMEDI.

KMS Group is associated with 3 legal entities: Kms Medisurgi Limited, Kms Manufacturing Limited, Kms Stock Broking Company Private Limited.

The legal entities of KMS Group currently have 10 directors, including Rekha Devang Kanakia, Gaurang Prataprai Kanakia, Siddharth Gaurang Kanakia and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available